VVUS - I think the FDA will go with the panel recommendation and ask for a CV outcomes study before approving. Risk with SSRI can be managed via label warning.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.